[go: up one dir, main page]

WO2006117803A3 - Transmucosal drug delivery systems - Google Patents

Transmucosal drug delivery systems Download PDF

Info

Publication number
WO2006117803A3
WO2006117803A3 PCT/IN2006/000089 IN2006000089W WO2006117803A3 WO 2006117803 A3 WO2006117803 A3 WO 2006117803A3 IN 2006000089 W IN2006000089 W IN 2006000089W WO 2006117803 A3 WO2006117803 A3 WO 2006117803A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug delivery
delivery systems
transmucosal drug
active agent
rapid release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2006/000089
Other languages
French (fr)
Other versions
WO2006117803A2 (en
Inventor
Milind Rajaram Redkar
Rahul Ramesh Shelke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2006117803A2 publication Critical patent/WO2006117803A2/en
Publication of WO2006117803A3 publication Critical patent/WO2006117803A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Transmucosal drug delivery systems comprise an inert core and a coating layer comprising at least one active agent, at least one bioadhesive substance, at least one plasticizer, and optionally one or more pharmaceutically acceptable excipients. The transmucosal drug delivery systems are designed to remain localized on mucosal surfaces while providing high surface area for rapid release of the pharmaceutically active agent or rapid release of a fraction of the pharmaceutically active agent followed by sustained delivery.
PCT/IN2006/000089 2005-03-14 2006-03-13 Transmucosal drug delivery systems Ceased WO2006117803A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN282/MUM/2005 2005-03-14
IN282MU2005 2005-03-14

Publications (2)

Publication Number Publication Date
WO2006117803A2 WO2006117803A2 (en) 2006-11-09
WO2006117803A3 true WO2006117803A3 (en) 2007-01-25

Family

ID=37075672

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000089 Ceased WO2006117803A2 (en) 2005-03-14 2006-03-13 Transmucosal drug delivery systems

Country Status (1)

Country Link
WO (1) WO2006117803A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2197424A2 (en) * 2007-10-17 2010-06-23 Pharmathen S.A. Improved pharmaceutical composition containing antiviral agent and method for the preparation thereof
KR101245604B1 (en) 2007-11-13 2013-03-21 메리테이지 파마, 인크. Corticosteroid compositions
US9498440B2 (en) * 2009-05-22 2016-11-22 Inventia Healthcare Private Limited Extended release pharmaceutical compositions
WO2013022924A1 (en) * 2011-08-08 2013-02-14 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations
WO2019006287A1 (en) 2017-06-29 2019-01-03 Skyline Biosciences, Llc Isotretinoin oral-mucosal formulations and methods for using same
WO2021171318A1 (en) * 2020-02-28 2021-09-02 Alkem Laboratories Ltd Transmucosal pharmaceutical composition of levocetirizine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168806B1 (en) * 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
WO2003059330A1 (en) * 2002-01-15 2003-07-24 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising ace inhibitor(s)
WO2005072079A2 (en) * 2003-09-26 2005-08-11 Alza Coporation Drug coating providing high drug loading and methods for providing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6168806B1 (en) * 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
WO2003059330A1 (en) * 2002-01-15 2003-07-24 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising ace inhibitor(s)
WO2005072079A2 (en) * 2003-09-26 2005-08-11 Alza Coporation Drug coating providing high drug loading and methods for providing the same

Also Published As

Publication number Publication date
WO2006117803A2 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
WO2004064815A8 (en) Oral dosage formulation
WO2007081948A3 (en) Bioadhesive drug formulations for oral transmucosal delivery
WO2008081891A1 (en) Orally disintegrating solid preparation
WO2008011169A3 (en) Controlled release formulations and associated methods
WO2004047794A3 (en) An allergen dosage form
EP1589947B8 (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration
UA95993C2 (en) Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
WO2008142627A3 (en) Multilayered modified release formulation comprising amoxicillin and clavulanate
WO2007135193A3 (en) Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means
AU2003210243A1 (en) Method for systemic drug delivery through the nail
WO2006039499A3 (en) Method for improving the biovailability of orally delivered therapeutics
WO2008022932A3 (en) Controlled release system and method for manufacturing the same
WO2010017821A8 (en) Coated tablets with a remaining degradation surface over the time
CL2007002000A1 (en) Pharmaceutical preparation for oral administration with controlled release of active ingredient in the small intestine comprising inert carriers, active ingredients, an inner layer composed of 2 diffusion layers to control the release and a gastro-resistant layer; Preparation method.
WO2006101882A3 (en) Medicament delivery formulations, devices and methods
WO2008152398A3 (en) Formulations for inhalation
WO2010052466A8 (en) Pharmaceutical aerosol composition
WO2007032993A3 (en) Surfactant systems for delivery of organic compounds
WO2007133944A3 (en) Topical administration of acyclovir
WO2006117803A3 (en) Transmucosal drug delivery systems
NO20091467L (en) Pharmaceutical formulations comprising clopidogrel
WO2006030402A3 (en) Dual compartment osmotic delivery device
WO2006123364A3 (en) Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative
WO2011058336A3 (en) Tablet comprising gum arabic
CA2566931A1 (en) Tablets exhibiting reduced drug release variability

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06766256

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 6766256

Country of ref document: EP